# The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders

> **NCT05900661** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Beni-Suef University** · enrollment: 300 (estimated)

## Conditions studied

- Poor Responders

## Interventions

- **DRUG:** myo-inositol
- **DRUG:** Somatropin
- **DRUG:** Dehydroepiandrosterone

## Key facts

- **NCT ID:** NCT05900661
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-30
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05900661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05900661, "The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05900661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*